Patients at Memorial Sloan Kettering who received the Codman pump lived about two years longer than those who did not, Dr. Kemeny and her colleagues reported last year, in the Journal of Clinical Oncology. They looked at 2,368 consecutive patients with colorectal cancer who had surgery to remove tumors that had spread to the liver. Those who received pumps (785) survived a median of 67 months, compared with 44 months for patients who did not get them (1,583). Dr. Kemeny began recommending the pump in the 1980s, and Memorial Sloan Kettering has been a leader in its use. But the surgeon also urged him to consult Dr. Kemeny.

Source: New York Times April 25, 2018 21:11 UTC